Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Mail-order patients go generic
Here's an unlikely enemy for brand-name drugmakers: mail-order pharmacies. Patients who fill their scrips via mail order are much more likely to choose generic drugs, according to two new studies. The exact figure was 34 percent more likely, which study sponsor Express Scripts hailed as a money-saver, but Pharma might lament as a revenue-drainer.
Two pieces of good news, though. The study only covered blood pressure meds, so generic choice might vary for other therapeutic classes. And if patients do order brand-name drugs via mail order, they're likely to be repeat customers. Compliance among mail-order patients was a full seven percentage points higher than among those who use retail pharmacies.
- read the Express Scripts release
Related Articles:
The specter of generic competition grows
Analysts get bullish on generics makers
Drug lobby stalls pro-generics bill
Say goodbye to Big Pharma's gilded age
Express Scripts mounts hostile offer for CaremarkRx (June 2006)
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


